GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Kenvue Inc (FRA:J4D) » Definitions » Debt-to-Revenue

Kenvue (FRA:J4D) Debt-to-Revenue : 0.60 (As of Dec. 2024)


View and export this data going back to 2023. Start your Free Trial

What is Kenvue Debt-to-Revenue?

Debt-to-Revenue measures a company's ability to pay off its debt.

Kenvue's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2024 was €1,517 Mil. Kenvue's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2024 was €6,810 Mil. Kenvue's annualized Revenue for the quarter that ended in Dec. 2024 was €13,989 Mil. Kenvue's annualized Debt-to-Revenue for the quarter that ended in Dec. 2024 was 0.60.


Kenvue Debt-to-Revenue Historical Data

The historical data trend for Kenvue's Debt-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kenvue Debt-to-Revenue Chart

Kenvue Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Debt-to-Revenue
Get a 7-Day Free Trial - 0.01 0.01 0.55 0.56

Kenvue Quarterly Data
Dec20 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Debt-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.58 0.56 0.54 0.57 0.60

Competitive Comparison of Kenvue's Debt-to-Revenue

For the Household & Personal Products subindustry, Kenvue's Debt-to-Revenue, along with its competitors' market caps and Debt-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Kenvue's Debt-to-Revenue Distribution in the Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, Kenvue's Debt-to-Revenue distribution charts can be found below:

* The bar in red indicates where Kenvue's Debt-to-Revenue falls into.


;
;

Kenvue Debt-to-Revenue Calculation

Debt-to-Revenue measures a company's ability to pay off its debt.

Kenvue's Debt-to-Revenue for the fiscal year that ended in Dec. 2024 is calculated as

Debt-to-Revenue=Total Debt / Revenue
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Revenue
=(1516.54 + 6810.105) / 14759.525
=0.56

Kenvue's annualized Debt-to-Revenue for the quarter that ended in Dec. 2024 is calculated as

Debt-to-Revenue=Total Debt / Revenue
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Revenue
=(1516.54 + 6810.105) / 13988.84
=0.60

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-Revenue, the Revenue of the last fiscal year is used. In calculating the annualized quarterly data, the Revenue data used here is four times the quarterly (Dec. 2024) Revenue data.


Kenvue Debt-to-Revenue Related Terms

Thank you for viewing the detailed overview of Kenvue's Debt-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Kenvue Business Description

Traded in Other Exchanges
Address
199 Grandview Road, Skillman, NJ, USA, 08558
Kenvue is the world's largest pure-play consumer health company by sales, generating $15 billion in annual revenue. Formerly known as Johnson & Johnson's consumer segment, Kenvue spun off and went public in May 2023. It operates in a variety of silos within consumer health, such as cough, cold and allergy care, pain management, face and body care, and oral care, as well as women's health. Its portfolio has some of the most well-known brands in the space, including Tylenol, Listerine, Johnson's, Aveeno, and Neutrogena. Despite playing in a fragmented industry with intense competition and changing consumer preferences, many of Kenvue's brands are the global leader in their respective segment thanks to their strong brand power.

Kenvue Headlines

No Headlines